Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 22459771)

1.

Response to add-on inhaled corticosteroids in COPD based on airway hyperresponsiveness to mannitol.

Scherr A, Schafroth Török S, Jochmann A, Miedinger D, Maier S, Taegtmeyer AB, Chhajed PN, Tamm MT, Leuppi JD.

Chest. 2012 Oct;142(4):919-26.

PMID:
22459771
2.
4.

Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept.

Leuppi JD, Tandjung R, Anderson SD, Stolz D, Brutsche MH, Bingisser R, Perruchoud AP, Surber C, Knoblauch A, Andersson M, Greiff L, Chan HK, Tamm M.

Pulm Pharmacol Ther. 2005;18(2):83-8. Epub 2004 Dec 21.

PMID:
15649849
5.

Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD.

Williamson PA, Short PM, Clearie KL, Vaidyanathan S, Fardon TC, Howaniec LJ, Lipworth BJ.

Chest. 2010 Sep;138(3):595-604. doi: 10.1378/chest.10-0247. Epub 2010 Apr 23.

PMID:
20418370
6.

Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.

Worth H, Förster K, Eriksson G, Nihlén U, Peterson S, Magnussen H.

Respir Med. 2010 Oct;104(10):1450-9. doi: 10.1016/j.rmed.2010.07.006. Epub 2010 Aug 7.

7.
8.

Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.

Brannan JD, Koskela H, Anderson SD, Chan HK.

Respirology. 2002 Mar;7(1):37-44.

PMID:
11896899
9.

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study.

Ställberg B, Selroos O, Vogelmeier C, Andersson E, Ekström T, Larsson K.

Respir Res. 2009 Feb 19;10:11. doi: 10.1186/1465-9921-10-11.

10.

Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.

Sharafkhaneh A, Southard JG, Goldman M, Uryniak T, Martin UJ.

Respir Med. 2012 Feb;106(2):257-68. doi: 10.1016/j.rmed.2011.07.020. Epub 2011 Oct 26.

13.

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.

Vestbo J, Sørensen T, Lange P, Brix A, Torre P, Viskum K.

Lancet. 1999 May 29;353(9167):1819-23.

PMID:
10359405
14.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

PMID:
22161409
15.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759
17.

Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Yang IA, Clarke MS, Sim EH, Fong KM.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD002991. doi: 10.1002/14651858.CD002991.pub3. Review.

PMID:
22786484
18.

Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.

Lipworth BJ, Sims EJ, Das SK, Buck H, Paterson M.

Ann Allergy Asthma Immunol. 2005 Jun;94(6):675-81.

PMID:
15984601
19.

Inhaled mannitol improves lung function in cystic fibrosis.

Jaques A, Daviskas E, Turton JA, McKay K, Cooper P, Stirling RG, Robertson CF, Bye PT, Lesouëf PN, Shadbolt B, Anderson SD, Charlton B.

Chest. 2008 Jun;133(6):1388-96. doi: 10.1378/chest.07-2294. Epub 2008 Mar 13.

PMID:
18339790
20.

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.

Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, Kessler R.

Am J Respir Crit Care Med. 2009 Oct 15;180(8):741-50. doi: 10.1164/rccm.200904-0492OC. Epub 2009 Jul 30.

PMID:
19644045
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk